Fate Therapeutics (FATE) Preferred Shares (2016 - 2026)
Fate Therapeutics (FATE) posted Preferred Shares of $3000.0 for Q1 2026, little changed on a QoQ basis from $3000.0 in Q4 2025, and little changed year-over-year from $3000.0 in Q1 2025.
Fate Therapeutics (FATE) Preferred Shares (2016 - 2026) Analysis & Trends
Fate Therapeutics' Preferred Shares history runs 11 years deep, the most recent figure standing at $3000.0 for Q1 2026.
- Quarterly Preferred Shares changed 0.0% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $3000.0, changed 0.0% from the prior year.
- Preferred Shares was $3000.0 for Q1 2026 at Fate Therapeutics, roughly flat from $3000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $3000.0 in Q1 2022 and bottomed at $3000.0 in Q1 2022.
- A 5-year average of $3000.0 and a median of $3000.0 in 2022 frame the typical range for Preferred Shares.
- Peak annual rise in Preferred Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Fate Therapeutics' Preferred Shares stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- Business Quant data shows FATE's Preferred Shares at $3000.0 in Q1 2026, $3000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |